<DOC>
	<DOCNO>NCT02177435</DOCNO>
	<brief_summary>Study demonstrate fix dose combination telmisartan 80 mg plus hydrochlorothiazide ( HCTZ ) 12.5 mg ( FDC 80/12.5 ) superior telmisartan 80 mg ( Telm 80 ) alone patient fail respond adequately Telm 80 monotherapy lowering seat trough diastolic blood pressure ( DBP ) eight week treatment .</brief_summary>
	<brief_title>Telmisartan With Without Hydrochlorothiazide Patients With Mild-to-moderate Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Telmisartan</mesh_term>
	<mesh_term>Hydrochlorothiazide</mesh_term>
	<criteria>History mildtomoderate hypertension Patients fail respond adequately telmisartan monotherapy Participants 18 80 year age Ability provide write informed consent Patients take three antihypertensive medication screen visit Premenopausal woman ( last menstruation ≤ 1 year prior start screen ) Who surgically sterile ( hysterectomy , tubal ligation ) Who NOT practice acceptable mean birth control NOT plan continue use acceptable method throughout study Any woman : Who positive serum pregnancy test screening ( Visit 1 ) baseline ( Visit 4 ) Who nurse Hepatic and/or renal dysfunction define follow laboratory parameter : SGPT ( ALT ) ( serum glutamate pyruvate transaminase ) SGOT ( AST ) ( serum glutamate oxaloacetate transaminase ) great two time upper limit normal Serum creatinine &gt; 2.3 mg/dL Clinically relevant sodium depletion , hyperkalemia , hypokalemia baseline Known suspect secondary hypertension Bilateral renal artery stenosis ; renal artery stenosis solitary kidney ; postrenal transplant patient , presence one functioning kidney Congestive heart failure ( CHF ) ( NYHA ( New York Heart Association ) class CHF IIIIV ) Unstable angina within past three month Stroke within past six month Myocardial infarction cardiac surgery within past three month PTCA ( percutaneous transluminal coronary angioplasty ) within past three month History angioedema Sustained ventricular tachycardia , atrial fibrillation , atrial flutter clinically relevant cardiac arrhythmia determine investigator Hypertrophic obstructive cardiomyopathy , aortic stenosis , hemodynamically relevant stenosis aortic mitral valve Administration digoxin digitalistype drug Patients insulin treat Type II diabetes mellitus whose diabetes stable control least past three month define HbA1C ≥ 10 % Known drug alcohol dependency within past one year period Concomitant administration medication know affect blood pressure , except medication allow protocol Patients receive investigational therapy within one month signing informed consent form . Patients participate previous telmisartan study may participate study provide least one month discontinue previous study sign consent present study Known hypersensitivity component formulation Any clinical condition , opinion investigator , would allow safe completion protocol safe administration trial medication</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>